Company Overview
Arecor Limited is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Wednesday 23 May 2007, so this is a well established company. Arecor Limited has been in business for 18 years and 10 months. The accounts status is full and the accounts are next due on Wednesday 30 September 2026.
Registered Address

Chesterford Research Park, Little Chesterford, Saffron Walden, CB10 1XL
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameARECOR LIMITED
Company Number06256698
Registered Office AddressChesterford Research Park
 CB10 1XL
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date23/05/2007
Accounting Reference Date Day31
Accounting Reference Date Month12
Accounts Next Due Date30/09/2026
Accounts Last Made Up Date31/12/2024
Accounts Account CategoryFULL
Returns Next Due Date20/06/2017
Returns Last Made Up Date23/05/2016
Directors & Members
Show Resigned
David Ellam - Director
(British, 63 years old, born October 1963)
Appointed 24 March 2025
 Active
Sarah Howell - Director
(British, 51 years old, born October 1975)
Appointed 26 October 2011
 Active
Jan Jezek - Director
(Czech, 55 years old, born November 1971)
Appointed 17 July 2024
 Active
Secretaries
Show Resigned
Other Company Directorships
David Ellam
BEECH GROWTH LIMITED
JUVENESCENCE UK LTD
RELATION THERAPEUTICS LIMITED
TETRIS PHARMA LTD
Sarah Howell
ARECOR THERAPEUTICS PLC
TETRIS PHARMA LTD
Jan Jezek
TETRIS PHARMA LTD
Balance Sheet Unlock full report
Accounts Date 31-Dec-2024 31-May-2014 31-May-2013
Balance Sheet
Fixed Assets 357,249 357,249 320,922
Current Assets 1,359,209 1,359,209 1,160,934
Creditors Due Within One Year 843,111 843,111 727,948
Working Cap 516,098 516,098 432,986
Total Assets Less Current Liabilities 873,347 873,347 753,908
Long-term Liabilities 244,639 244,639 255,979
Net Assets 628,708 628,708 497,929
Share Capital & Reserves
Share Cap 13,801 13,801 13,651
Profit & Loss Reserves -3,945,255 -3,945,255 -4,075,885
Other Reserves 4,560,162 4,560,162 4,560,163
Shareholders Funds 628,708 628,708 497,929
Common Size Financial Analysis Unlock full report
Accounts Date 31-Dec-2024 31-May-2014 31-May-2013
Tangible Fixed Assets - - -
Fixed Assets 20.8% 20.8% 21.7%
Stocks Inventory 0.0% 0.0% 0.5%
Debtors 37.9% 37.9% 42.2%
Cash Bank In Hand 41.3% 41.3% 35.6%
Current Assets 79.2% 79.2% 78.3%
Creditors Due Within One Year 49.1% 49.1% 49.1%
Net Current Assets Liabilities 30.1% 30.1% 29.2%
Creditors Due After One Year 14.3% 14.3% 17.3%
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability 36.6% 36.6% 33.6%
Called Up Share Capital 0.8% 0.8% 0.9%
Share Capital Allotted Called Up Paid 0.8% 0.8% 0.9%
Profit Loss Account Reserve -229.8% -229.8% -275.1%
Shareholder Funds 36.6% 36.6% 33.6%
Capital Employed - - -
Total Assets Less Current Liabilities 50.9% 50.9% 50.9%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Dec-2024 31-May-2014 31-May-2013
Liquidity Ratio 1.6 1.6 1.6
Solvency Ratio 1.6 1.6 1.5
Reserves to Assets -2.3 -2.3 -2.8
Secured Creditors Unlock full report
Mortgages Charges 2
Mortgages Outstanding 1
Mortgages Part Satisfied 0
Mortgages Satisfied 1
Assets and Debt Analysis Unlock full report
Accounts Date 31-Dec-2024 31-May-2014 31-May-2013
Assets 1,716,458 1,716,458 1,481,856
Debt 1,087,750 1,087,750 983,927
Net Assets/Debt 628,708 628,708 497,929

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around CB10 1XL
XENOVIDA LIMITED
Suite 8, The Mansion Chesterford Park, Little Chesterford, Saffron Walden, CB10 1XL
CAMBRIDGE LEADERSHIP LIMITED
25 Chesterford Research Park, Cambridge, CB10 1XL
MATERIALS INTELLIGENCE LIMITED
SUITE 12, THE MANSION, CHESTERFORD RESEARCH PARK, LITTLE CHESTERFORD, CAMBRIDGESHIRE, CB10 1XL
FUTURE MATERIALS CONSULTING LIMITED
SUITE 12, THE MANSION, CHESTERFORD RESEARCH PARK, LITTLE CHESTERFORD, CAMBRIDGESHIRE, CB10 1XL
FUTURE MATERIALS GROUP LIMITED
SUITE 12, THE MANSION, CHESTERFORD RESEARCH PARK, LITTLE CHESTERFORD, CAMBRIDGESHIRE, CB10 1XL
ISOGENICA LIMITED
THE MANSION CHESTERFORD RESEARCH PARK, LITTLE CHESTERFORD, SAFFRON WALDEN, ESSEX, CB10 1XL
ONCOLOGICA UK LIMITED
SUITE 2, GARDEN COTTAGE CHESTERFORD RESEARCH PARK, LITTLE CHESTERFORD, SAFFRON WALDEN, ESSEX, CB10 1XL
CELLCENTRIC LIMITED
CHESTERFORD RESEARCH PARK, LITTLE CHESTERFORD, CAMBRIDGE, CB10 1XL
ILLUMINA CAMBRIDGE LIMITED
19 GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, CAMBRIDGESHIRE, CB10 1XL
CAMNET DATA COMMUNICATIONS LIMITED
17 ASH GREEN, GREAT CHESTERFORD, SAFFRON WALDEN, CB10 1XL
Document Filings
Registration of charge 062566980002, created on 24 September 2025
Confirmation statement made on 22 May 2025 with no updates
Appointment of Mr David John Ellam as a director on 24 March 2025
Change of details for Arecor Therapeutics Plc as a person with significant control on 23 July 2021
Termination of appointment of Susan Day Lowther as a secretary on 17 July 2024
Appointment of Dr Jan Jezek as a director on 17 July 2024
Termination of appointment of Susan Day Lowther as a director on 17 July 2024
Confirmation statement made on 22 May 2024 with updates
Confirmation statement made on 22 May 2023 with updates
Confirmation statement made on 23 May 2022 with updates
Memorandum and Articles of Association
Resolutions
Notification of Arecor Therapeutics Plc as a person with significant control on 23 July 2021
Withdrawal of a person with significant control statement on 9 August 2021
Termination of appointment of Alan Smith as a director on 21 June 2021
Termination of appointment of Andrew John Mcglashan Richards as a director on 21 June 2021
Termination of appointment of Mohammad Sohail Fazeli as a director on 21 June 2021
Memorandum and Articles of Association
Resolutions
Resolutions
Memorandum and Articles of Association
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free